The evaluation of the study included the potential impact of SNPs of the CRP gene (rs1130864, rs1417938, rs1800947, rs3093077) as well as CRP plasma level on a combined CV endpoint (CV death, death from stroke, myocardial infarction (MI), and stroke/transient ischemic attack (TIA)). The gene discussed is CRP; the disease is Stroke.